Patterns of avoidance behaviours in the light/dark preference test in young juvenile zebrafish: A pharmacological study

Behavioural Brain Research

Volumn 222, Issue 1, 2011, Pages 15-25

  Steenbergen, Peter J ^a,b   Richardson, Michael K ^a   Champagne, Danielle L ^a,b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anxiety; Assay; Pharmacology; Stress; Young juvenile

Indexed keywords

ALCOHOL; BUSPIRONE; CAFFEINE; DIAZEPAM; N METHYL BETA CARBOLINE 3 CARBOXAMIDE;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DARKNESS; FEMALE; JUVENILE ANIMAL; LATENT PERIOD; LIGHT DARK PREFERENCE TEST; LOCOMOTION; MALE; NEUROLOGIC EXAMINATION; NONHUMAN; PRIORITY JOURNAL; ZEBRA FISH;

ADAPTATION, OCULAR; ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BIAS (EPIDEMIOLOGY); CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; ESCAPE REACTION; FEMALE; LARVA; MALE; MOTOR ACTIVITY; REACTION TIME; SPATIAL BEHAVIOR; ZEBRAFISH;

EID: 79953715171     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.03.025     Document Type: Article

References (59)

1. Serra E.L., Medalha C.C., Mattioli R. Natural preference of zebrafish (Danio rerio) for a dark environment. Braz J Med Biol Res 1999, 32:1551-1553.
2. Maximino C., Marques de Brito T., Dias C.A., Gouveia A., Morato S. Scototaxis as anxiety-like behavior in fish. Nat Protoc 2010, 5:209-216.
3. Maximino C., de Brito T.M., Colmanetti R., Pontes A.A., de Castro H.M., de Lacerda R.I., et al. Parametric analyses of anxiety in zebrafish scototaxis. Behav Brain Res 2010, 210:1-7.
4. Lopez-Patino M.A., Yu L., Cabral H., Zhdanova I.V. Anxiogenic effects of cocaine withdrawal in zebrafish. Physiol Behav 2008, 93:160-171.
5. Guo S. Using zebrafish to assess the impact of drugs on neural development and function. Expert Opin Drug Discov 2009, 4:715-726.
6. Guo S. Linking genes to brain, behavior and neurological diseases: what can we learn from zebrafish?. Genes Brain Behav 2004, 3:63-74.
7. Gerlai R. Zebrafish antipredatory responses: a future for translational research?. Behav Brain Res 2010, 207:223-231.
8. Egan R.J., Bergner C.L., Hart P.C., Cachat J.M., Canavello P.R., Elegante M.F., et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 2009, 205:38-44.
9. Champagne D.L., Hoefnagels C.C., de Kloet R.E., Richardson M.K. Translating rodent behavioral repertoire to zebrafish (Danio rerio): relevance for stress research. Behav Brain Res 2010, 214:332-342.
10. Cachat J., Canavello P., Elegante M., Bartels B., Hart P., Bergner C., et al. Modeling withdrawal syndrome in zebrafish. Behav Brain Res 2010, 208:371-376.
11. Blaser R.E., Chadwick L., McGinnis G.C. Behavioral measures of anxiety in zebrafish (Danio rerio). Behav Brain Res 2010, 208:56-62.
12. Bencan Z., Sledge D., Levin E.D. Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. Pharmacol Biochem Behav 2009, 94:75-80.
13. Sousa N., Almeida O.F., Wotjak C.T. A hitchhiker's guide to behavioral analysis in laboratory rodents. Genes Brain Behav 2006, 5(Suppl. 2):5-24.
14. Bourin M., Hascoet M. The mouse light/dark box test. Eur J Pharmacol 2003, 463:55-65.
15. Hascoet M., Bourin M., Dhonnchadha B.A. The mouse light-dark paradigm: a review. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:141-166.
16. Belzung C., Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 2001, 125:141-149.
17. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003, 463:3-33.
18. Pellow S., Chopin P., File S.E., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14:149-167.
19. Steenbergen P.J., Richardson M.K., Champagne D.L. The use of the zebrafish model in stress research. Prog Neuropsychopharmacol Biol Psychiatry 2010.
20. Sackerman J., Donegan J.J., Cunningham C.S., Nguyen N.N., Lawless K., Long A., et al. Zebrafish behavior in novel environments: effects of acute exposure to anxiolytic compounds and choice of Danio rerio line. Int J Comp Psychol 2010, 23:43-61.
21. Lopez Patino M.A., Yu L., Yamamoto B.K., Zhdanova I.V. Gender differences in zebrafish responses to cocaine withdrawal. Physiol Behav 2008, 95:36-47.
22. Grossman L., Utterback E., Stewart A., Gaikwad S., Chung K.M., Suciu C., et al. Characterization of behavioral and endocrine effects of LSD on zebrafish. Behav Brain Res 2010, 214:277-284.
23. Gerlai R., Lahav M., Guo S., Rosenthal A. Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav 2000, 67:773-782.
24. Maximino C., de Brito T.M., da Silva Batista A.W., Herculano A.M., Morato S., Gouveia A. Measuring anxiety in zebrafish: a critical review. Behav Brain Res 2010, 214:157-171.
25. Stewart A., Wu N., Cachat J., Hart P., Gaikwad S., Wong K., et al. Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models. Prog Neuropsychopharmacol Biol Psychiatry 2010.
26. Markou A., Chiamulera C., Geyer M.A., Tricklebank M., Steckler T. Removing obstacles in neuroscience drug discovery: the future path for animal models. Neuropsychopharmacology 2009, 34:74-89.
27. Anisman H., Matheson K. Stress, depression, and anhedonia: caveats concerning animal models. Neurosci Biobehav Rev 2005, 29:525-546.
28. Agid Y., Buzsaki G., Diamond D.M., Frackowiak R., Giedd J., Girault J.A., et al. How can drug discovery for psychiatric disorders be improved?. Nat Rev Drug Discov 2007, 6:189-201.
29. Rihel J., Prober D.A., Arvanites A., Lam K., Zimmerman S., Jang S., et al. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 2010, 327:348-351.
30. Peterson R.T. Drug discovery: propping up a destructive regime. Nature 2009, 461:599-600.
31. Kokel D., Peterson R.T. Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish. Brief Funct Genomic Proteomic 2008, 7:483-490.
32. Kokel D., Bryan J., Laggner C., White R., Cheung C.Y., Mateus R., et al. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol 2010.
33. Brittijn S.A., Duivesteijn S.J., Belmamoune M., Bertens L.F., Bitter W., de Bruijn J.D., et al. Zebrafish development and regeneration: new tools for biomedical research. Int J Dev Biol 2009, 53:835-850.
34. Best J.D., Alderton W.K. Zebrafish: an in vivo model for the study of neurological diseases. Neuropsychiatr Dis Treat 2008, 4:567-576.
35. Best J.D., Berghmans S., Hunt J.J., Clarke S.C., Fleming A., Goldsmith P., et al. Non-associative learning in larval zebrafish. Neuropsychopharmacology 2008, 33:1206-1215.
36. Emran F., Rihel J., Dowling J.E. A behavioral assay to measure responsiveness of zebrafish to changes in light intensities. J Vis Exp 2008.
37. Irons T.D., Macphail R.C., Hunter D.L., Padilla S. Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicol Teratol 2010, 32:84-90.
38. Lockwood B., Bjerke S., Kobayashi K., Guo S. Acute effects of alcohol on larval zebrafish: a genetic system for large-scale screening. Pharmacol Biochem Behav 2004, 77:647-654.
39. Drapeau P., Saint-Amant L., Buss R.R., Chong M., McDearmid J.R., Brustein E. Development of the locomotor network in zebrafish. Prog Neurobiol 2002, 68:85-111.
40. Speedie N., Gerlai R. Alarm substance induced behavioral responses in zebrafish (Danio rerio). Behav Brain Res 2008, 188:168-177.
41. Gerlai R. High-throughput behavioral screens: the first step towards finding genes involved in vertebrate brain function using zebrafish. Molecules 2010, 15:2609-2622.
42. Cachat J., Stewart A., Grossman L., Gaikwad S., Kadri F., Chung K.M., et al. Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nat Protoc 2010, 5:1786-1799.
43. Nusslein-Volhard C., Dahm R. Zebrafish: paractical approach 2005, Oxford University Press, Tubingen.
44. Bouwknecht J.A., Paylor R. Pitfalls in the interpretation of genetic and pharmacological effects on anxiety-like behaviour in rodents. Behav Pharmacol 2008, 19:385-402.
45. Belzung C., Philippot P. Anxiety from a phylogenetic perspective: is there a qualitative difference between human and animal anxiety?. Neural Plast 2007, 2007:59676.
46. Wong K., Elegante M., Bartels B., Elkhayat S., Tien D., Roy S., et al. Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res 2010, 208:450-457.
47. MacPhail R.C., Brooks J., Hunter D.L., Padnos B., Irons T.D., Padilla S. Locomotion in larval zebrafish: influence of time of day, lighting and ethanol. Neurotoxicology 2009, 30:52-58.
48. Burgess H.A., Granato M. Modulation of locomotor activity in larval zebrafish during light adaptation. J Exp Biol 2007, 210:2526-2539.
49. Varsamos S., Flik G., Pepin J.F., Bonga S.E., Breuil G. Husbandry stress during early life stages affects the stress response and health status of juvenile sea bass, Dicentrarchus labrax. Fish Shellfish Immunol 2006, 20:83-96.
50. Tian J., Wei M., Liang P.J., Sun F. Effects of diazepam on closed- and open-loop optokinetic nystagmus (OKN) in humans. Exp Brain Res 2003, 152:523-527.
51. Elder M.J. Diazepam and its effects on visual fields. Aust N Z J Ophthalmol 1992, 20:267-270.
52. File S.E., Baldwin H.A. Effects of beta-carbolines in animal models of anxiety. Brain Res Bull 1987, 19:293-299.
53. Evans A.K., Lowry C.A. Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects. CNS Drug Rev 2007, 13:475-501.
54. Shanbhogue R., Hrishikeshavan H.J., Devi K., Munonyedi S. Behavioral neurobiology of inverse agonist FG 7142 induced anxiety syndrome in rats. Prog Neuropsychopharmacol Biol Psychiatry 1990, 14:249-260.
55. Stevenson C.W., Halliday D.M., Marsden C.A., Mason R. Systemic administration of the benzodiazepine receptor partial inverse agonist FG-7142 disrupts corticolimbic network interactions. Synapse 2007, 61:646-663.
56. Dorow R., Duka T., Holler L., Sauerbrey N. Clinical perspectives of beta-carbolines from first studies in humans. Brain Res Bull 1987, 19:319-326.
57. Dorow R. FG 7142 and its anxiety-inducing effects in humans. Br J Clin Pharmacol 1987, 23:781-782.
58. Sena L.M., Bueno C., Pobbe R.L., Andrade T.G., Zangrossi H., Viana M.B. The dorsal raphe nucleus exerts opposed control on generalized anxiety and panic-related defensive responses in rats. Behav Brain Res 2003, 142:125-133.
59. Maximino C., da Silva A.W., Gouveia A., Herculano A.M. Pharmacological analysis of zebrafish (Danio rerio) scototaxis. Prog Neuropsychopharmacol Biol Psychiatry 2011.